| Residential College | false |
| Status | 已發表Published |
| Human Gut Microbial β-Glucuronidase Inhibition: An Emerging Approach to Manage Medication Therapy | |
Wang, Panpan; Jia, Yifei; Wu, Rongrong; Chen, Zhiqiang; YAN RU 
| |
| 2021-04 | |
| Source Publication | Biochemical Pharmacology
 |
| Volume | 190Pages:114566 |
| Keyword | Gut Microbiota Gut Microbial Β-glucuronidases Inhibition Medication Therapy |
| Document Type | Journal article |
| Collection | Institute of Chinese Medical Sciences |
| Corresponding Author | YAN RU |
| Affiliation | Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau |
| First Author Affilication | Institute of Chinese Medical Sciences |
| Corresponding Author Affilication | Institute of Chinese Medical Sciences |
| Recommended Citation GB/T 7714 | Wang, Panpan,Jia, Yifei,Wu, Rongrong,et al. Human Gut Microbial β-Glucuronidase Inhibition: An Emerging Approach to Manage Medication Therapy[J]. Biochemical Pharmacology, 2021, 190, 114566. |
| APA | Wang, Panpan., Jia, Yifei., Wu, Rongrong., Chen, Zhiqiang., & YAN RU (2021). Human Gut Microbial β-Glucuronidase Inhibition: An Emerging Approach to Manage Medication Therapy. Biochemical Pharmacology, 190, 114566. |
| MLA | Wang, Panpan,et al."Human Gut Microbial β-Glucuronidase Inhibition: An Emerging Approach to Manage Medication Therapy".Biochemical Pharmacology 190(2021):114566. |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment